Literature DB >> 8016786

Diffuse panbronchiolitis and cystic fibrosis: East meets West.

N Høiby.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8016786      PMCID： PMC474936          DOI： 10.1136/thx.49.6.531

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  26 in total

Review 1.  Testing the susceptibility of bacteria in biofilms to antibacterial agents.

Authors:  H Anwar; M K Dasgupta; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1990-11       Impact factor: 5.191

Review 2.  Pathogenesis of cystic fibrosis.

Authors:  C Koch; N Høiby
Journal:  Lancet       Date:  1993-04-24       Impact factor: 79.321

3.  Lysosomal enzymes from polymorphonuclear leukocytes and proteinase inhibitors in patients with cystic fibrosis.

Authors:  W Goldstein; G Döring
Journal:  Am Rev Respir Dis       Date:  1986-07

4.  Aerosol alpha 1-antitrypsin treatment for cystic fibrosis.

Authors:  N G McElvaney; R C Hubbard; P Birrer; M S Chernick; D B Caplan; M M Frank; R G Crystal
Journal:  Lancet       Date:  1991-02-16       Impact factor: 79.321

5.  Elevation of plasma truncated elastase alpha 1-proteinase inhibitor complexes in patients with inflammatory lung diseases.

Authors:  J Fujita; H Nakamura; Y Yamagishi; Y Yamaji; T Shiotani; S Irino
Journal:  Chest       Date:  1992-07       Impact factor: 9.410

6.  Erythromycin inhibits the production of elastase by Pseudomonas aeruginosa without affecting its proliferation in vitro.

Authors:  K Sakata; H Yajima; K Tanaka; Y Sakamoto; K Yamamoto; A Yoshida; Y Dohi
Journal:  Am Rev Respir Dis       Date:  1993-10

7.  Bronchial responsiveness and acute bronchodilator response in chronic obstructive pulmonary disease and diffuse panbronchiolitis.

Authors:  H Koyama; K Nishimura; T Mio; A Ikeda; N Sugiura; T Izumi
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

8.  Effect of long term treatment with oxitropium bromide on airway secretion in chronic bronchitis and diffuse panbronchiolitis.

Authors:  J Tamaoki; A Chiyotani; E Tagaya; N Sakai; K Konno
Journal:  Thorax       Date:  1994-06       Impact factor: 9.139

9.  Analysis of IgA antibody to Pseudomonas aeruginosa in sera and sputa of patients with chronic airway diseases.

Authors:  Y Noda; S Yasuoka; I Inoue; K Tani; K Fujisawa; T Ogura
Journal:  Intern Med       Date:  1992-05       Impact factor: 1.271

10.  Long-term low-dose administration of erythromycin to patients with diffuse panbronchiolitis.

Authors:  H Nagai; H Shishido; R Yoneda; E Yamaguchi; A Tamura; A Kurashima
Journal:  Respiration       Date:  1991       Impact factor: 3.580
View more
  28 in total

1.  Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa.

Authors:  K Tateda; R Comte; J C Pechere; T Köhler; K Yamaguchi; C Van Delden
Journal:  Antimicrob Agents Chemother       Date:  2001-06       Impact factor: 5.191

Review 2.  Macrolides in the respiratory tract in cystic fibrosis.

Authors:  Adam Jaffé; Mark Rosenthal
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

3.  The Pseudomonas aeruginosa autoinducer N-3-oxododecanoyl homoserine lactone accelerates apoptosis in macrophages and neutrophils.

Authors:  Kazuhiro Tateda; Yoshikazu Ishii; Manabu Horikawa; Tetsuya Matsumoto; Shinichi Miyairi; Jean Claude Pechere; Theodore J Standiford; Masaji Ishiguro; Keizo Yamaguchi
Journal:  Infect Immun       Date:  2003-10       Impact factor: 3.441

4.  Effect of Sub-MICs of Macrolides on the Sensitivity of Pseudomonas aeruginosa to Nitrosative Stress: Effectiveness against P. aeruginosa with and without Multidrug Resistance.

Authors:  Takeshi Shimizu; Tohru Miyoshi-Akiyama; Kohei Ogura; Shota Murata; Shota Ishige; Kiyohiro Kai; Konosuke Mitsutsuka; Haruyoshi Tomita; Koichi Tanimoto; Akio Matsumoto
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

Review 5.  How has research in the last five years changed my clinical practice?

Authors:  A Bush
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

Review 6.  Exploiting quorum sensing to confuse bacterial pathogens.

Authors:  Breah LaSarre; Michael J Federle
Journal:  Microbiol Mol Biol Rev       Date:  2013-03       Impact factor: 11.056

Review 7.  Treatment of severe small airways disease in children with cystic fibrosis: alternatives to corticosteroids.

Authors:  Adam Jaffe; Ian M Balfour-Lynn
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 8.  Use of modulators of airways inflammation in patients with CF.

Authors:  Clement L Ren
Journal:  Clin Rev Allergy Immunol       Date:  2002-08       Impact factor: 8.667

9.  Two novel synthetic peptides inhibit quorum sensing-dependent biofilm formation and some virulence factors in Pseudomonas aeruginosa PAO1.

Authors:  Mostafa N Taha; Amal E Saafan; A Ahmedy; Eman El Gebaly; Ahmed S Khairalla
Journal:  J Microbiol       Date:  2019-06-27       Impact factor: 3.422

Review 10.  Macrolide antibiotics for cystic fibrosis.

Authors:  Kevin W Southern; Pierre M Barker; Arturo Solis-Moya; Latifa Patel
Journal:  Cochrane Database Syst Rev       Date:  2012-11-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.